Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Pharmaceutical Technology

08:17 EDT 27th May 2018 | BioPortfolio

Here are the most relevant search results for "Pharmaceutical Technology" found in our extensive news archives from over 250 global news sources.

More Information about Pharmaceutical Technology on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Pharmaceutical Technology for you to read. Along with our medical data and news we also list Pharmaceutical Technology Clinical Trials, which are updated daily. BioPortfolio also has a large database of Pharmaceutical Technology Companies for you to search.

Showing News Articles 1–25 of 614 from Pharmaceutical Technology

Friday 25th May 2018

EMA post-Brexit: will the UK become a second-tier state?

On 17 May the Business, Energy and Industrial Strategy (BEIS) Committee released a report detailing the consequences of the UK...Read More... The post EMA post-Brexit: will the UK become a second-tier state? appeared first on Pharmaceutical Technology.

ASGCT 2018: does pricing allow fair access to gene-based therapies?

The 2018 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting was held at the Hilton Chicago in Chicago,...Read More... The post ASGCT 2018: does pricing allow fair access to gene-based therapies? appeared first on Pharmaceutical Technology.

Global biosimilar market forecast to reach $99.28bn by 2024

Global market research and consulting organisation Infoholic Research has concluded that the global biosimilar drugs market will experience a compound...Read More... The post Global biosimilar market forecast to reach $99.28bn by 2024 appeared first on Pharmaceutical Technology.

FDA to decide on Teva’s migraine treatment by September

Israel-based pharmaceutical company Teva has announced confirmation that the US Food and Drugs Administration (FDA) will make a decision on...Read More... The post FDA to decide on Teva’s migraine treatment by September appeared first on Pharmaceutical Technology.

Is artificial intelligence the future of drug discovery?

The applications of artificial intelligence (AI) in healthcare are numerous, with the potential to transform key aspects of the industry,...Read More... The post Is artificial intelligence the future of drug discovery? appeared first on Pharmaceutical Technology.

Thursday 24th May 2018

European Commission approves Sandoz’s biosimilar Zessly

Novartis’ subsidiary Sandoz has secured approval from the European Commission (EC) for its biosimilar product Zessly (infliximab) to treat gastroenterological,...Read More... The post European Commission approves Sandoz’s biosimilar Zessly appeared first on Pharmaceutical Technology.

Report: Pharma professionals in UK do not expect relocation after Brexit

Majority of global healthcare professionals in UK-based companies do not anticipate staff relocations post Brexit, according to a survey by...Read More... The post Report: Pharma professionals in UK do not expect relocation after Brexit appeared first on Pharmaceutical Technology.

Deals this week: Cipla, Takeda Pharmaceutical, Cadila Healthcare

Indian pharmaceutical company Cipla plans to issue non-convertible debentures or bonds through a public offering or a private placement to...Read More... The post Deals this week: Cipla, Takeda Pharmaceutical, Cadila Healthcare appeared first on Pharmaceutical Technology.

Pfizer gets breakthrough status from FDA for cardiomyopathy drug

The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to Pfizer’s tafamidis to treat patients suffering from...Read More... The post Pfizer gets breakthrough status from FDA for cardiomyopathy drug appeared first on Pharmaceutical Technology.

Merck claims chemotherapy more effective when combined with its Keytruda

Merck has announced the results from its Phase 3 Keynote-407 trial that suggest combining its Keytruda therapy with carboplatin-paclitaxel or...Read More... The post Merck claims chemotherapy more effective when combined with its Keytruda appeared first on Pharmaceutical Technology.

Esperion reports success from study to reduce LDL-C levels

Lipid management company Esperion has announced positive results for its third Phase 3 study into the efficacy of bempedoic acid...Read More... The post Esperion reports success from study to reduce LDL-C levels appeared first on Pharmaceutical Technology.

Pharma Technology Focus – Issue 71

Pharma Technology Focus is now available on all devices. Read it for free here. Analysts are predicting a surge of M&A...Read More... The post Pharma Technology Focus – Issue 71 appeared first on Pharmaceutical Technology.

FDA certifies new drug for thrombocytopenia

The US Food and Drug Administration (FDA) has approved Dova Pharmaceuticals’ Doptelet drug for patients with thrombocytopenia, a reduction in...Read More... The post FDA certifies new drug for thrombocytopenia appeared first on Pharmaceutical Technology.

Aimovig marks a new milestone for migraine

Amgen’s Aimovig (erenumab) was recently approved by the FDA for the prevention of migraine; it is expected to launch in...Read More... The post Aimovig marks a new milestone for migraine appeared first on Pharmaceutical Technology.

Strengthening DFS’ core should be Tim Stacey’s focus as new CEO

Ian Filby, CEO of DFS, is stepping down in November 2018 after eight years, to be replaced by Tim Stacey,...Read More... The post Strengthening DFS’ core should be Tim Stacey’s focus as new CEO appeared first on Pharmaceutical Technology.

China’s enrolment rate dips as phase rises

Figure 1: Enrolment rate by trial phase in China. Credit: GlobalData. On average, enrolment rates for clinical trials in China,...Read More... The post China’s enrolment rate dips as phase rises appeared first on Pharmaceutical Technology.

Wednesday 23rd May 2018

Allergan to buy Aptinyx’s depression drug candidate

Allergan has decided to acquire biopharmaceutical firm Aptinyx’s drug candidate AGN-241751 and advance it as a treatment for major depressive...Read More... The post Allergan to buy Aptinyx’s depression drug candidate appeared first on Pharmaceutical Technology.

FDA reviews Sanofi’s application for type 1 diabetes drug

The US Food and Drug Administration (FDA) has accepted Sanofi’s regulatory submission to review the use of Zynquista as a...Read More... The post FDA reviews Sanofi’s application for type 1 diabetes drug appeared first on Pharmaceutical Technology.

Amgen forms new alliances to improve cancer outcomes

Amgen has formed new partnerships to initiate the new Linking & Amplifying User-Centered Networks through Connected Health (L.A.U.N.C.H) programme aimed...Read More... The post Amgen forms new alliances to improve cancer outcomes appeared first on Pharmaceutical Technology.

Takeda sells stake in Techpool after acquiring Shire

Japanese pharmaceutical company Takeda has divested its 51.34% majority share of Chinese Guangdong Techpool Bio-Pharma after acquiring rare disease biotechnology...Read More... The post Takeda sells stake in Techpool after acquiring Shire appeared first on Pharmaceutical Technology.

Breakthroughs for haemophilia gene therapies

Two pharmaceutical companies, BioMarin and Spark, have announced positive results of their separate phase 1/2 studies of treatments for haemophilia...Read More... The post Breakthroughs for haemophilia gene therapies appeared first on Pharmaceutical Technology.

CRISPR: a seismic shift in gene editing

Given the ubiquity of CRISPR today, it’s hard to believe that the technology was little more than a blip on...Read More... The post CRISPR: a seismic shift in gene editing appeared first on Pharmaceutical Technology.

US Congress approves ‘right-to-try’ bill

The US House of Representatives has passed a ‘right-to-try’ bill that would allow terminally ill patients to seek drugs that...Read More... The post US Congress approves ‘right-to-try’ bill appeared first on Pharmaceutical Technology.

FDA names and shames companies inhibiting generics manufacturing

The US Food and Drugs Administration (FDA) has released a list of pharmaceutical companies it believes are making it harder...Read More... The post FDA names and shames companies inhibiting generics manufacturing appeared first on Pharmaceutical Technology.

Tuesday 22nd May 2018

Evotec signs cancer drug development alliance with Celgene

German pharmaceutical firm Evotec has signed a drug discovery and development alliance with Celgene to identify new therapies for treating...Read More... The post Evotec signs cancer drug development alliance with Celgene appeared first on Pharmaceutical Technology.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks